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THE CELL MEMBRANE is a recognized site
for radiation injury (Myers, 1970; Alper,
1971). Chemical agents known to interact
with membrane components may therefore
amplify cell killing when present during
irradiation. Indeed membrane-active
agents such as local anaesthetics, anal-
gesics and tranquillizers have been shown
to enhance radiation effects on cells
(George et al., 1975; Shenoy et al., 1975).
A commonly used tranquillizer, chlor-
promazine HCI (CPZ), has shown great
promise in increasing the radiation sensi-
tivity ofhypoxic bacterial and mammalian
cells in vitro (Shenoy et al., 1975) as well
as mouse solid tumours in vivo (George
et al., 1980; Shenoy & Singh, 1980).
This drug also showed preferential cyto-
toxicity to hypoxic bacterial cells (Shenoy
& Singh, 1978) and a mouse fibrosarcoma
in vivo (George et al., 1980).
Since the plasma membrane is also the
main organelle involved in heat-killing
of cells (Har-Kedar & Bleehen, 1976)
CPZ, by virtue of its membrane activity,
might potentiate the therapeutic effect
of hyperthermia. We have therefore in-
vestigated the effect ofCPZ on the thermal
sensitivity of two murine solid tumours
in vivo.
The tumours used in the present study
were a sarcoma 180 (Si80) and a fibro-
sarcoma described elsewhere (Shenoy &
Singh, 1980: George et al., 1980). Both
were serially transplantable and grown
s.c. on the ventral wall of the thorax of
8-week-old female Swiss mice weighing
Accepte(d 19 October 1981
19-25 g. When the tumours reached a
mean diameter of 7 + 1 or 8 + 1 mm for
8180 and the fibrosarcoma respectively,
they were randomly distributed between
4 groups comprising control animals and
those receiving CPZ or heat or both.
Pharmaceutical-grade CPZ (May & Baker
Ltd, India) was dissolved in sterile normal
saline at a concentration of 0-25 mg/ml.
To ensure maximum drug level at the
site, CPZ at a dose of 5 mg/kg body wt
was given as a single injection with a
27-gauge needle in a volume of 0-38-
0 5 ml solution directly to the centre of
the tumours in unanaesthetized animals
5 min before heating. The control animals
received an equal volume of normal
saline. Usually no haemorrhage or necrosis
of the tumour was observed after such
treatments. If any such effects were not-
iced, the animal was discarded.
Experiments using radioactive CPZ
(35S) revealed that with this mode of
injection the drug level in the tumour
remained constant for more than 60 min.
All heat treatments oftumours were there-
fore given for 1 h, excluding the time
taken by the tumour to attain the maxi-
mum temperature. Tumours were heated
by laying the animals horizontally in
specially designed jigs with holes, through
which the tumours could protrude down-
wards to be fully immersed in the water-
bath. Animals were gently held in position
by adhesive tapes. Heating the tumours
was carried out in a thermostatically
controlled ( + 01- C) circulating waterbathK. C. GEORGE AND B. B. SINGH
(Gallenkam), England). Cool air was
blown across the water bath to reduce the
humidity of the inspired air as well as to
prevent the body temperature from rising.
Intratumour temperatures were measured
separately in a different set of animals,
by needle thermocouple probe in associa-
tion with a direct-reading electric thermo-
meter (Omega Engineering, Inc., U.S.A.).
The probe was inserted s.c. above the
water level and passed down to the centre
of the tumour to minimize errors in
temperature reading due to heat conduc-
tion along the probe. Within 5-10 min
both the tuniours attained a temperature
0 5 + 0 2°C less than that of the water-
bath, and maintained it throughout the
duration of the heating. Although the
temperature across a tumour may vary
considerably, the intratumour tempera-
ture referred to in our report is the central
tumour temperature. Rectal tempera-
tures were measured by a YSI thermistor
tele-thermometer (Yellow Springs Instru-
ment Co. Inc., U.S.A.).
Tumouir growth delay was used as the
criterion for assessing the response to
various treatments. After each treatment
tumours were measured with calipers
thrice a week in 3 mutually perpendicular
directions, and a geometric mean was
calculated. When the tumours reached a
mean diameter of - 13 mm and the
animals looked sick, they were killed.
The effectiveness of the treatment was
measured from the average time taken by
the tumours to reach a diameter of 11 mm
after each treatment. The cured animals
were maintained up to 90 days and then
killed, after ascertaining that no palp-
able tumour was present.
In animals bearing fibrosarcoma and
8180, it has been earlier demonstrated
that a non-toxic dose of 40 mg/kg body
wt of CPZ was required to obtain signifi-
cant delay in the tumour growth at body
temperature (George et al., 1980; Shenoy
& Singh, 1980). At high temperatures
(40.5-42*50C) in the tumour (when the
body temperature increased to 37 5°C,
however) drug doses > 5 mg/kg proved
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FIe. 1. Effect of chliorpromazine an(l hyper-
thiermia on mouse sarcoma S180. In this
and the other figure, error bars show + s.e.
The starting diameter was 7 + 1 mm. Num-
ber of tumours per group 6-9. 0 O,
control; 0-- -O, CPZ 5 mg/kg; x - x,
heat 40 5°C (tumour core, I h); x - - - x,
CPZ+40-5C;A A, 41 5°C; A- -A
CPZ+41-5°C; ,42-5°C; C- ,
CPZ + 42 50C.
lethal. In the present series of experi-
ments detailed toxicity studies were not
carried out, but a non-lethal dose of the
drug (5 mg/kg) was maintained.
Fig. 1 shows the growth characteristics
of S180 after CPZ and heat treatments.
Neither treatment with CPZ alone nor
heating at 40 5°C influenced tumour
growth. However, marginal delay in
tumour growth was indicated when these
treatments were combined. Heat alone
at 41-5 or 42-50C completely regressed
this tumour. The mean periods for tumour
disappearance at these temperatures were
16 2 + 0 6 and 9 8 + 0 7 days respectively.
Whereas only a marginal effect could be
seen on the combined treatment with
drug plus heat at 41 5°C (growth delay=
15 8 + 0*7 days), hardly any drug effect
could be noticed over the heat effect at
42-50C. These results thus indicate the
ineffectiveness of CPZ in S180 at elevated
temperatures.
For the fibrosarcoma, the growth rate
and the average time taken to reach a
diameter of II mm after CPZ and heat
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FIG. 2.-Effect of chlorpromazine and hyper-
thermia on mouse fibrosarcoma. The
starting diameter was 8+1 mm. Number
of tumours per group 7-11. 0 O,
control; x x,CPZ 5mg/kg; A A,
heat 41iO0C (tumour core, 1 h); A---A,
CPZ+41i0°C; O D,42O0°C; O- - -D,
CPZ +42 O0C.
TABLE.-Effect of chlorpromazine and
hyperthermia on a mouse fibrosarcoma
Con
CPZ
Hea
Time (days)
to reach
11 mm
diameter
Treatment (mean+s.e.)
,trol 4*3 + 0*4
5 mg/kg 4 3 +O- 3
tt41iC 4 9+0 3
(tumour core, I h)
Heat 42°C, 1 h
CPZ +41°C
CPZ +42°C
The starting diamete
tumours in each group X
Delay in
tumour
growth
(days +s.e.)
0-6+0-5
5-2+0-2 09+O05
5 7+0 5 1i4+0-6
9-8+0-9 5-5+1 0
-r is 8+1 mm. Number of
was 7-11.
treatments are shown in Fig. 2 and the
Table respectively. Here again, neither
the drug alone nor heat alone at
41°C, or a combination thereof, produced
any significant delay. In contrast, ad-
ministration of CPZ before heating the
tumours to 42°C caused substantial delay
in the growth compared to tumours
heated without the drug (Fig. 2 and
Table). No cures were detected in these
experiments, however.
The response of these tumours to heat
alone is consistent with the general
findings reported earlier, that tempera-
tures below 41-50C have no pronounced
effect (Crile, 1962; Overgard & Overgard,
1972; Stewart & Denekamp, 1978).
Growth of some tumours has, however,
been controlled by local heat treatments
at higher temperatures (Crile, 1963; Over-
gard & Overgard, 1972). In the present
study, heating of tumours to 41b50C for
1 h caused complete disappearance of
S180, indicating its high heat sensitivity.
On the other hand, the fibrosarcoma
showed less heat sensitivity, since heat,
even at 42°C, produced little growth
delay. These tumours also differ in their
response to the combined action of CPZ
and hyperthermia, as discussed above.
Since the fibrosarcoma was initially pro-
duced and maintained in an inbred strain
of Swiss mice it is non-immunogenic
(Sahasrabudhe et al., 1977). On the other
hand, S180 is believed to be immunogenic
(S. Sato, NCRI, Tokyo, personal com-
munication). Whether their differential
response to heat and CPZ can be attri-
buted to this factor needs further investi-
gation. However, it is known that the
fluidity of a cell membrane plays a major
role in its sensitivity to heat (Yatvin,
1977). Since CPZ and other membrane-
active drugs fluidize membrane lipids
(Seeman, 1972; Feinstein et al., 1975;
Papahadjopoulos et al., 1975; Singer, 1977)
an interaction between the effects of such
drugs and heat is expected. The different
responses of S180 and the fibrosarcoma
to the combined treatment with CPZ
and heat may therefore also be attribut-
able to differences in the membrane
fluidity of these two tumour lines.
With a view to ascertaining this possi-
bility, fluorescence-polarization studies
were carried out using 1,6-diphenyl-1,3,5-
hexatriene (DPH) as a hydrophobic
fluorescent probe. Single-cell suspensions
of the fibrosarcoma and S180 were pre-
pared by trypsinization. Cells suspended
in phosphate-buffered saline (pH 7.2) at
a concentration of 107 cells/ml were equi-
librated with 1OtUM DPH for 1 h at room
temperature in a water-bath shaker.
The polarization of fluorescent light
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(Amax 430 nm) was measured with the
help of an Amnico Bowman spectrophoto-
fluorimeter equipped with Glan polarizers.
The polarization factor P was calculated as
P'IEE-IEB
IEE+IEB
where IEE and IEB are the intensities of
fluorescent light with the excitation polar-
izer always set at the E position,
and the emission polarizer set at E
and B positions respectively. Suitable
corrections to IEB were made to account
for scattering from cells as well as for
relative transmission of the emission
monochromator. The polarization factor
for fibrosarcoma (P=0-202 + 0.005) was
significantly different from that for S180
(P=0.180+0.002). As P is a direct meas-
ure of the fluidity of the hydrophobic
region of the membrane, these results
indicate that the S180 membrane is rela-
tively more fluid than that of fibrosar-
coma, which may account for its greater
heat sensitivity. Although no such com-
parative measurements on tumours with
different heat or drug sensitivities have
been made, several investigations into
P values of normal and transformed cells
have been reported, with varying results
(Fuchs et al., 1975; Edward et al., 1976;
Hatten et al., 1978; Monti et al., 1979).
Different P values have been reported
for cells even of the same origin but with
different morphologies. A gradient across
the membrane for P has also been ob-
served (Schroeder, 1980). In view of these
facts, our present interpretation of the
relationship between hyperthermic re-
sponse and P values of two tumour lines
may appear an over-simplication. They
nevertheless open a possible new dimen-
sion to our understanding of the hyper-
thermic response of cells.
The present indicator that CPZ may be
a hypoxic cell radiosensitizer, gives some
promise for its use in a combined modality
for cancer treatment.
The investigation was partly supported by the
International Atomic Energy Agency, Vienna
Contract No. RC/1396/R5/RB).
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